Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
about
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate LyaseFuranodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner.Evaluating bempedoic acid for the treatment of hyperlipidaemia.Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation.Calorie restriction prevents the development of insulin resistance and impaired lipid metabolism in gestational diabetes offspring.Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer.Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment.
P2860
Q28067422-BE3FB2D4-0433-46A6-91CE-7D3812767184Q38785419-463C6431-CDDF-4CBF-9286-6C55B9048998Q39074339-20AB6C24-2FF6-40D9-8E8C-FD9DD4E3CF30Q49647329-14E2A3CB-CB20-432B-A8FE-4AF07DC59AD8Q50466809-029D9BDF-71C4-49CE-9360-2E5A80DD7E7BQ52659536-BCE2F191-ACAC-4EA3-A7E7-59529F2B6820Q55464963-1353A4A7-508B-4AB5-9C4F-CD2B0E516D0C
P2860
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
@ast
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
@en
type
label
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
@ast
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
@en
prefLabel
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
@ast
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
@en
P1476
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
@en
P2093
Carlos O Mendivil
Hernán N Lemus
P304
P356
10.1016/J.JACL.2015.01.002
P407
P577
2015-01-14T00:00:00Z